Laren D. Tan, MD, MD, MBA

He earned a BS in Cytology at Loma Linda University School of Allied Health (2003) and an MD at Loma Linda University (2009) before completing a residency in Internal Medicine at Loma Linda University Medical Center (2012) and a fellowship in Pulmonary and Critical Care at the University of California at Davis. Dr. Tan joined the Loma Linda University faculty as Assistant Professor of Medicine in 2015. He is the author of multiple articles in scientific journals including: Benralizumab: a unique IL-5 inhibitor for severe asthma; Bronchial Thermoplasty: Implementing Best Practice in the Common Era; Patient-Centered Structured Interdisciplinary Bedside Rounds in the Medical Intensive Care Unit; and additional articles in professional journals such as Bronchial Thermoplasty: A Decade of Experience: State of The Art.

In 2015, Dr. Tan became Medical Director of Loma Linda University’s Hyperbaric Medicine Program—the first and largest hyperbaric program in the region to achieve national and international accreditation by the Undersea and Hyperbaric Medical Society (2017). After his 2015 appointment as Medical Director of Loma Linda University’s Hospital Wound Operation Services in 2015, his top priority was to enable the medical center to become one of the region’s leaders in wound care. In May 2017, for the first time ever, the hospital achieved over a year of below-benchmark-pressure ulcer prevalence.

The creator and director of the university’s Comprehensive Program for Obstructive Airway Diseases, Dr. Tan has led in the development of the most comprehensive and cutting-edge chronic obstructive pulmonary disease, asthma, non-tuberculous mycobacterium, and bronchiectasis program on the West Coast. During his tenure as Director, the university has become one of the premier West Coast sites providing bronchial thermoplasty care—and has achieved national recognition as a center of excellence for the provision of this therapy. The program has also become the regional referral center for advanced biologic therapy for severe asthmatics. As part of the interdisciplinary obstructive airway disease team, Dr. Tan provides comprehensive personalized conventional and advanced therapies for patients with the most severe obstructive airway diseases.

Dr. Tan’s other interests include praying for the medically ill, intrapreneurship, entrepreneurship, precision marketing, and innovative solutions to current health care challenges. He is chief and the creator of Center for Innovation and Promotions within the Department of Medicine at Loma Linda University Health. The center utilizes innovative ways to promote internally and externally the achievements and high quality work that medicine and its subspecialty physicians perform. He is also the creator and president of Ignis Medical Innovations, a medical technology think tank that seeks to examine and solve local and global health care needs. He has organized prayer seminars to assist health care providers and medical learners in meeting the spiritual needs of patients and their families. He has facilitated the academic and professional education of physicians in a variety of contexts outside the university. He has presented at sessions of the American College of Chest Physicians, California Thoracic Society, American Lung Association, Inland Empire Health Plans (IEHP), at Riverside County events, at programs organized by the Office of the Mayor of the City of Riverside and is an active participant in conversations about the State of California medical policies.

EDUCATION AND TRAINING

7/2015            Fellowship                   University of California, Davis                         Pulmonary & CriticalCare Medicine

7/2012            Residency                    Loma Linda University , Loma Linda                Internal Medicine

7/2010            Internship                    Loma Linda University, Loma Linda                 Internal Medicine

7/2009            M.D.                            Loma Linda University, Loma Linda              

7/2003            B.S.                            Loma Linda University, Loma Linda                 SAHP, Cytology

7/2015             Primary Hyperbaric International ATMO, San Antonio, TX                    Hyperbaric Medicine

BOARD CERTIFICATION

2016 - Present             American Board of Internal Medicine – Critical Care Medicine                              

2015 - Present             American Board of Internal Medicine – Pulmonary Medicine                     

2015 - Present             California Department of Public Health – Fluoroscopy Licensed Operator           

2014 - Present             American Board of Internal Medicine                                                                        

2003 - 2005                 American Society for Clinical Pathology Board Certified - Cytotechnology               

Medical Board of Physician and Surgeon      2010 - Present

ACADEMIC HISTORY

LLUH FMG Director,                         LLUH Faculty Medical Group                     2020 – Present

            Creative Innovations, Communications and Strategic Branding

Associate Professor                             Internal Medicine, LLU                         2020 – Present

Associate Director for Advanced        Loma Linda University Health                  2019 – Present

            Lung Disease Center

Chief, Center for Innovation &           Internal Medicine, LLU                           2018 – Present

            Promotions

Associate Program Director                Internal Medicine, LLU                           2018 – Present

Assistant Professor                              Internal Medicine, LLU                         2015 – 2019               

EMPLOYMENT APPOINTMENTS

Attending        Internal Medicine                    Loma Linda University                2015 – Present

Fellow             Internal Medicine                    UC Davis Medical Center             2012 – 2015

Resident          Internal Medicine                    Loma Linda University                2010 – 2012   

Intern              Internal Medicine                    Loma Linda University                2009 – 2010

1. Tan L, Chupp G, Castro M, Kraft M. Going Beyond “Bio-markers”, think “Life-markers”. CHEST. 2020; Volume 157, Issue 3, 503 – 505.
2. Tan LD, Schaeffer B, Alismail A. Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: Not Everything is What it Seems. Journal of Asthma and Allergy 2019;12:415-420
3. Fung, A.G.*; Tan, L.D.*; Duong, T.N.; Schivo, M.; Littlefield, L.; Delplanque, J.P.; Davis, C.E.; Kenyon, N.J. Design and Benchmark Testing for Open Architecture Reconfigurable Mobile Spirometer and Exhaled Breath Monitor with GPS and Data Telemetry. Diagnostics 2019, 9, 100.                                                                 
4. Alismail A, Thomas J, Daher NS, Cohen A, Almutairi W, Terry MH, Huang C, Tan LD. Augmented reality glasses improve adherence to evidence-based intubation practice. Adv Med Educ Pract 2019:10;279-286.
5. Sung-gyu Kim M, Van Perre K, Leininger D, Tan L. Squamous Cell Esophageal Cancer: A Peculiar Case and Pattern of Metastasis to the Ring Finger. Ann Clin Case Rep. 2019; 4: 1643.
6. Quan M, Frankel S, Maleki-Fischbach M, Tan LD. A rare case report of polyangitis overlap syndrome: granulomatosis with polyangitis and eosinophilic granulomatosis with polyangitis. BMC Pulmonary Medicine. 2018; 18:181
7. Alismail A, Nayak S, Casillas P, Lopez D, Tan L. Bronchial Thermoplasty in Severe Asthmatics: Pre and Post Anxiety Levels. Respiratory Care. Oct 2018, 63 (Suppl 10) 3022725.
8. Alismail A, Nayak S, Casillas P, Lopez D, Tan L. Post Bronchial Thermoplasty Discharge in Severe Asthmatics. Respiratory Care. Oct 2018, 63 (Suppl 10) 3025968.
9. Tan LD, Yoneda KY, Louie S, Hogarth DK, Castro M. Bronchial Thermoplasty: A Decade of Experience: State of the Art. J Allergy Clin Immunol Pract. 2019 Jan;7(1):71-80.
10. Cohen A, Tan L, Fargo R, Anholm JD, Gasho C, Yaqub K, Chopra S, Hansen J, Huang C, Moretta D, Washburn D, Bryant Nguyen H. A multi-center evaluation of a disposable catheter to aid in correct positioning of the endotracheal tube after intubation in critically ill patients. J Crit Care. 2018 Sep 6;48:222-227.
11. Perez SD, Molinaro CA, Tan L, ThyagaRajan S, Lorton D, Bellinger DL. Sympathetic neurotransmission in spleens from aging Brown-Norway rats subjected to reduced sympathetic tone. J Neuroimmunol. 2018 Aug 18;324:1-15.
12. Gan A, Cohen A, Tan L. Augmented Reality-Assisted Percutaneous Dilatational Tracheostomy in Critically Ill Patients With Chronic Respiratory Disease. Journal of Intensive Care Medicine. 2019 Feb;34(2):153-155.
13. Huang C.Y., Thomas J, Alismail A, Cohen A, Almutari W, Daher N, Terry M, Tan LD.The use of augmented reality glasses in central line simulation: see one simulate many, do one competently and teach everyone. Advances in Medical Education and Practice 2018; 9:357-363
14. Alismail A, Massey E, Song C, Daher N, Terry M, Lopez D, Tan L, Lo T. Emotional Impact of Cardiopulmonary Resuscitation Training on High School Students. Front. Public Health 2018; 5:362
15. Cao V, Tan LD, Femke H, Bland D, Giri P, Maken K, Cho N, Scott L, Dinh VA, Hidalgo D, Nguyen HB. Patient-Centered Structured Interdisciplinary Bedside Rounds in the Medical Intensive Care Unit. Critical Care Medicine: January 2018; 46(1):85–92
16. L.D. Tan, N. Kenyon, K.Y. Yoneda, S. Louie. Bronchial Thermoplasty: Implementing Best Practice in the Common Era. Journal of Asthma and Allergy 2017; 10: 225-230
17. Tan L, Louie S. Unresolved Acute Pneumonia: a “Bad OMEN”. Consultant360 2017;57(8):500-503.
18. Moretta D, Gasho C, Denham L, Tan L. A Complicated Case of Dyspnea. Journal of Advances in Medicine and Medical Research 2017; 23(3): 1-8
19. Tan LD, Bratt JM, Godor D, Louie S, Kenyon NJ. Benralizumab: a unique IL-5 inhibitor for severe asthma. Journal of Asthma and Allergy 2016; 9:83-91
20. Sharma AP, Alismail A, Massey E, Song C, Tan L. An Unexpected Sequelae of a Routine Cardiopulmonary Resuscitation. JSM Clin Case Rep 2016; 4(2): 1100
21. Tan L, Poon C, Harper R. The Snow Globe Effect” Journal of Scientific Medicine Clinical Case Reports. 2014; 3(1): 1073
22. Tan LD, Chan AL, Albertson TE. New Combination Treatments in the Management of Asthma: Focus on Fluticasone/vilanterol. Journal of Asthma and Allergy 2014;7:7–83
23. Tan L, Louie S. The Danger of Hemoptysis. Consultant 360 2014: 54
24. Perez SD, Silva D, Millar AB, Molinaro CA, Carter J, Bassett K, Lorton D, Garcia P, Tan L, Gross J, Lubahn C, Thyagarajan S, Bellinger DL. Sympathetic innervation of the spleen in male Brown Norway rats: a longitudinal aging study. Brain Res. 2009 Dec 11;1302:106-17.

ABSTRACT & POSTER PRESENTATIONS